Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Frontiers in Bioscience : a Journal and Virtual Library
|
June 16, 2007
The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein
Yongxia Qu, Victor Adler, Lara Izotova, et al.
Cancer Chemotherapy and Pharmacology
|
June 5, 2003
Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growth
Mecheal Kanovsky, Josef Michl, Georgia Botzolaki, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 2, 2013
Identification of 2-piperidone as a biomarker of CYP2E1 activity through metabolomic phenotyping
Jie Cheng, Chi Chen, Krausz W Kristopher, et al.
International Journal of Cancer
|
May 12, 2006
PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo
Josef Michl, Bruce Scharf, Anna Schmidt, et al.
Annals of Clinical and Laboratory Science
|
March 5, 2008
Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase
Victor Adler, Wilbur Bowne, Josef Michl, et al.
Biochemistry
|
August 10, 2005
Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway
Victor Adler, Yongxia Qu, Steven J Smith, et al.
Oncogene
|
March 12, 2003
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site
Tamara N Do, Ramon V Rosal, Lisa Drew, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Frontiers in Bioscience : a Journal and Virtual Library
|
June 16, 2007
The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein
Yongxia Qu, Victor Adler, Lara Izotova, et al.
Cancer Chemotherapy and Pharmacology
|
June 5, 2003
Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growth
Mecheal Kanovsky, Josef Michl, Georgia Botzolaki, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 2, 2013
Identification of 2-piperidone as a biomarker of CYP2E1 activity through metabolomic phenotyping
Jie Cheng, Chi Chen, Krausz W Kristopher, et al.
International Journal of Cancer
|
May 12, 2006
PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo
Josef Michl, Bruce Scharf, Anna Schmidt, et al.
Annals of Clinical and Laboratory Science
|
March 5, 2008
Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase
Victor Adler, Wilbur Bowne, Josef Michl, et al.
Biochemistry
|
August 10, 2005
Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway
Victor Adler, Yongxia Qu, Steven J Smith, et al.
Oncogene
|
March 12, 2003
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site
Tamara N Do, Ramon V Rosal, Lisa Drew, et al.
Page
of 2